What is Invasive Lobular Carcinoma?
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer after invasive ductal carcinoma, accounting for about 10% of all breast cancer cases. It begins in the lobules (milk-producing glands) of the breast and invades surrounding tissues. Unlike some other types of breast cancer, ILC tends to be more diffusely spread through the breast and is often harder to detect both by physical examination and mammography.
Symptoms
The symptoms of invasive lobular carcinoma can be less noticeable than those of other breast cancers and may include:
- A thickening or hardening in the breast tissue that feels different from the surrounding tissue.
- Slight swelling or fullness in one part of the breast.
- Changes in the texture or appearance of the skin on the breast, such as dimpling or puckering.
- An inverted nipple or changes in the nipple’s appearance.
- Sometimes, there may be no noticeable symptoms.
Disease Aetiology (Causes)
The exact cause of ILC, like many cancers, is not fully understood. Risk factors include age, family history of breast cancer, hormonal factors, personal history of breast diseases, and lifestyle factors.
Diagnosis
Diagnosing ILC often involves:
- Mammography: But note that ILC can be more challenging to detect.
- Ultrasound or MRI: These imaging tests can be more effective in identifying ILC.
- Biopsy: Essential for a definitive diagnosis and involves taking a sample of breast tissue for analysis.
- Hormone Receptor and HER2/neu Testing: To determine if the cancer is responsive to hormonal therapies or targeted therapies.
Treatment
Treatment for ILC typically includes a combination of approaches:
- Surgery: Either a lumpectomy (removing the cancer and some normal tissue around it) or mastectomy (removal of the entire breast).
- Radiation Therapy: Usually recommended following lumpectomy.
- Chemotherapy: May be used before or after surgery to reduce the risk of recurrence.
- Hormone Therapy: For hormone receptor-positive cancers, which is common with ILC.
- Targeted Therapy: Depending on the cancer’s specific characteristics.
What support can we give for the Invasive Lobular Carcinoma?
Invasive Lobular Carcinoma is a rare cancer, meaning it is not as well-known as other forms of cancer. Without a Ribbon is an Australian organisation that provides support for individuals who suffer from rare cancers. So, we provide a designated platform for Warriors to obtain information specific to their Rare Cancer. We also provide annual opportunities for our Warriors to meet and learn from each other. If you suffer from rare cancer such as Invasive Lobular Carcinoma, we can help and support you through your journey thanks to the generous donations we receive. Click the link below to sign up and become a Warrior today!
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:
